rs1064792905
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM1PM2PM4PP3PP5_Very_Strong
The ENST00000558518.6(LDLR):c.646_657delAGGAAAACTGCG(p.Cys216_Gly219del) variant causes a conservative inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
ENST00000558518.6 conservative_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LDLR | NM_000527.5 | c.683_694delAGGAAAACTGCG | p.Glu228_Cys231del | disruptive_inframe_deletion, splice_region_variant | Exon 4 of 18 | ENST00000558518.6 | NP_000518.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hypercholesterolemia, familial, 1 Pathogenic:1
Disrupt SDE motif. SDE bind structural Ca2+. -
Cardiovascular phenotype Pathogenic:1
The c.683_694del12 variant (also known as p.E228_C231del) is located in coding exon 4 of the LDLR gene. This variant results from an in-frame AGGAAAACTGCG deletion at nucleotide positions 683 to 694 at the end of exon 4. This results in the deletion of four amino acids between codons 228 and 231. This alteration has been reported in a cohort of subjects with familial hypercholesterolemia (Tichý L et al. Physiol Res, 2017 Apr;66:S47-S54). In addition, internal structural analysis indicates that this alteration both alters the conserved SDE triplet motif and disrupts a disulfide bond in the LDL type A repeat 5, which is important for ligand binding (Ambry internal data). Based on four different splice site prediction tools, this alteration is expected to create an in-frame alternate splice donor site at the new exon-intron boundary created by the deletion; however, experimental evidence is not currently available. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Familial hypercholesterolemia Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. At least two different substitutions within this deleted sequence (p.Gln228Gln and p.Cys231Gly) have been determined to be pathogenic (PMID: 8882879, 16250003, 17094996, 8664907). This suggests that several residues within this region are critical for LDLR protein function. Algorithms developed to predict the effect of sequence changes on mRNA splicing suggest that this variant may alter RNA splicing, but this prediction has not been confirmed by published transcriptional studies. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a LDLR-related disease. This sequence change deletes 12 nucleotides from exon 4 of the LDLR mRNA (c.683_694delAGGAAAACTGCG). This leads to the deletion of 4 amino acid residues in the LDLR protein (p.Glu228_Cys231del) but otherwise preserves the integrity of the reading frame. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at